This article is rated Stub-class on Wikipedia's
content assessment scale. It is of interest to the following WikiProjects: | |||||||||||
|
Ideal sources for Wikipedia's health content are defined in the guideline
Wikipedia:Identifying reliable sources (medicine) and are typically
review articles. Here are links to possibly useful sources of information about Dihydroartemisinin.
|
-- 222.67.211.208 ( talk) 12:10, 2 March 2010 (UTC)
why not drugbox?-- Jsjsjs1111 ( talk) 07:28, 15 June 2012 (UTC)
"Alternatively, the same total dose may be given once daily for three days" - does that mean 3x the dose altogether? If not, could we clarify by saying "over three days" to avoid misunderstanding? It could potentially be life-threatening to get it wrong? (Even doctors may sometimes look here when no packaging is available in remote areas?) — Preceding unsigned comment added by 79.247.165.56 ( talk) 10:02, 5 October 2015 (UTC)
I'm pretty sure this is not standard form for describing the impact of studies. Can someone revise in a more wiki-compliant in-text manner? Thor214 ( talk) 15:37, 25 April 2017 (UTC)
The upper structure drawing is correct, but the 3D structure has a methoxy group instead of hydroxy. LDCorey ( talk) 16:01, 1 March 2018 (UTC)
There are errors in IUPAC name: (3R,5aS,6R,8aS,9R,12S,12aR)-Decahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin-10-ol
There is no 1,2-benzodioxepin
in compound, only 2-benzoxepin.
In fusion nomenclature bridges are given by prefixes (R-2.4.1.2.). That means atoms of brigdes are not counted in parent hydrides. Without -O-O- bridge there are 14 atoms in parent hydrid, 4 of them are common among more then one ring. So there is no atom number 12 as in prefix above. Pubchem and ChemSpider uses Baeyer nomenclature not fusion for dihydroartemisinin. Gyimhu ( talk) 22:19, 6 May 2020 (UTC)
This article is rated Stub-class on Wikipedia's
content assessment scale. It is of interest to the following WikiProjects: | |||||||||||
|
Ideal sources for Wikipedia's health content are defined in the guideline
Wikipedia:Identifying reliable sources (medicine) and are typically
review articles. Here are links to possibly useful sources of information about Dihydroartemisinin.
|
-- 222.67.211.208 ( talk) 12:10, 2 March 2010 (UTC)
why not drugbox?-- Jsjsjs1111 ( talk) 07:28, 15 June 2012 (UTC)
"Alternatively, the same total dose may be given once daily for three days" - does that mean 3x the dose altogether? If not, could we clarify by saying "over three days" to avoid misunderstanding? It could potentially be life-threatening to get it wrong? (Even doctors may sometimes look here when no packaging is available in remote areas?) — Preceding unsigned comment added by 79.247.165.56 ( talk) 10:02, 5 October 2015 (UTC)
I'm pretty sure this is not standard form for describing the impact of studies. Can someone revise in a more wiki-compliant in-text manner? Thor214 ( talk) 15:37, 25 April 2017 (UTC)
The upper structure drawing is correct, but the 3D structure has a methoxy group instead of hydroxy. LDCorey ( talk) 16:01, 1 March 2018 (UTC)
There are errors in IUPAC name: (3R,5aS,6R,8aS,9R,12S,12aR)-Decahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin-10-ol
There is no 1,2-benzodioxepin
in compound, only 2-benzoxepin.
In fusion nomenclature bridges are given by prefixes (R-2.4.1.2.). That means atoms of brigdes are not counted in parent hydrides. Without -O-O- bridge there are 14 atoms in parent hydrid, 4 of them are common among more then one ring. So there is no atom number 12 as in prefix above. Pubchem and ChemSpider uses Baeyer nomenclature not fusion for dihydroartemisinin. Gyimhu ( talk) 22:19, 6 May 2020 (UTC)